Pembrolizumab (Pembro) Vs Standard of Care (Soc) for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M Hnscc): Phase 3 Keynote-040 Trial

AuthID
P-00N-2XR
15
Author(s)
Harrington, KJ
·
Le Tourneau, C
·
Dinis, J
·
Licitra, L
·
Ahn, MJ
·
Soria, A
·
Machiels, JP
·
Mach, N
·
Mehra, R
·
Burtness, B
·
Wang, Y
·
Tuozzo, AJ
·
Swaby, R
·
Soulieres, D
Document Type
Abstract
Year published
2017
Published
in ANNALS OF ONCOLOGY, ISSN: 0923-7534
Volume: 28
Conference
42Nd European-Society-For-Medical-Oncology Congress (Esmo), Date: SEP 08-12, 2017, Location: Madrid, SPAIN, Sponsors: European Soc Med Oncol
Indexing
Publication Identifiers
Wos: WOS:000411324005100
Source Identifiers
ISSN: 0923-7534
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.